Web2 jul. 2024 · CONCLUSION The derived immune-protein signature combined with a rapid measurement platform is an accurate predictive tool for early detection of COVID-19 … WebMeMed’s vision is to improve the lives of patients through innovative technologies. We’re a rapidly growing inter-disciplinary team of professionals passionate about developing …
MeMed LinkedIn
Web7 jun. 2024 · In the future, we believe that this type of device will become a central and leading tool in the diagnosis and treatment of infectious diseases.” Dr. Eran Eden, CEO and co-founder of MeMed, ... Web4 jun. 2024 · June 4, 2024. MeMed has been granted CE mark certification for its MeMed Key assay platform and MeMed BV bacterial and viral infection diagnostic. The MeMed … heather zambito kdka
MeMed - Overview, News & Competitors ZoomInfo.com
WebMeMed Diagnostics has developed and validated an immune-based protein signature, MeMed BV, which distinguishes between bacterial and viral infections, providing a powerful tool in the fight against resistant strains of bacteria. An ELISA format of MeMed BV called ImmunoXpert is cleared for use in the EU (CE-IVD), Switzerland, and Israel and is ... Web29 sep. 2024 · Patent number: 11466331. Abstract: Methods of determining infection type are disclosed. In one embodiment, the method comprises measuring the amount of a determinant which is set forth in Tables 1 or 2 in a sample derived from the subject, wherein said amount is indicative of the infection type. Type: Grant. Filed: March 2, 2024. Web22 sep. 2024 · The test runs on the MeMed Key immunoassay platform that enables the measurement of multiple proteins without having to send samples to a remote laboratory for analysis. The “point-of-need” test … movies like madchen in uniform